EUVIMEDEUVIMED entdecken
Open Access

Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and function

Saumya Y Maru iD, Meredith Wetzel, Jacob T Mitchell, Nicole E Gross, Lalitya Andaloori, Kathryn Howe, Emma Kartalia, Guanglan Mo, James Leatherman, Won Jin Ho, Elana J Fertig, Luciane T Kagohara und 2 weitere

The Journal of Immunology · 07.06.2026 · 215 (6)

DOI: 10.1093/jimmun/vkag165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 29.06.2026. Verfasst von Saumya Y Maru und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, United States. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Cancer-Associated Fibroblasts, T-Lymphocytes, Regulatory, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Lustgarten Foundation, US National Institutes of Health, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is characterized by an immunosuppressive tumor microenvironment (TME) in which cancer-associated fibroblasts (CAFs) play pivotal roles in shaping therapeutic responses. Among these, MHC-II–expressing antigen-presenting CAFs (apCAFs) modulate CD4 T-cell activity, yet their contribution to the antitumor immune response remains unclear. Using tumor clones of the KPC murine PDAC model differing in sensitivity to immune checkpoint blockade (ICB), we show that immunosensitive (sKPC) tumors exhibit greater apCAF infiltration than resistant (rKPC) tumors. Reducing apCAF numbers in sKPC tumors impaired responsiveness to ICB, highlighting apCAFs’ role in mediating effective antitumor immunity. Ex vivo assays revealed that apCAFs from both models activate CD4 T cells and induce regulatory T-cell (Treg) differentiation. However, single-cell transcriptomics revealed that rKPC apCAFs promote Tregs with heightened immunosuppressive signatures, driven by distinct chemokine signaling. We identified elevated CCL22 expression and signaling in rKPC-derived apCAFs as a contributor to enhanced Treg-mediated suppression. Functional blockade of CCL22 reduced TGF-β secretion by rKPC apCAF-induced Tregs, supporting a mechanistic role for this pathway in fostering an immunosuppressive TME. These findings position apCAFs as regulators of CD4 T-cell antitumor immunity in PDAC and suggest that modulating apCAF–T-cell interactions could offer strategies to enhance immunotherapy efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCancer-Associated FibroblastsT-Lymphocytes, RegulatoryCarcinoma, Pancreatic DuctalAnimalsMiceTumor MicroenvironmentPhenotypeCell Line, TumorHumansMice, Inbred C57BLDisease Models, AnimalImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

T cellscancerrodentstromal cellstumor immunity

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, United States.
  • Department of Oncology, Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, United States.
  • Convergence Institute, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, United States.
  • Department of Medicine, Division of Hematology/Oncology, Greenbaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.
  • Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.

ORCID-Profile: Saumya Y Maru

Förderung

  • Lustgarten Foundation
  • US National Institutes of Health
  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Maru, S. Y., Wetzel, M., Mitchell, J. T., Gross, N. E., Andaloori, L., Howe, K., Kartalia, E., Mo, G., Leatherman, J., Ho, W. J., Fertig, E. J., Kagohara, L. T., Pearce, E. J., & Jaffee, E. M. (2026). Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and function. The Journal of Immunology, 215(6). https://doi.org/10.1093/jimmun/vkag165

Vancouver

Maru SY, Wetzel M, Mitchell JT, Gross NE, Andaloori L, Howe K, et al. Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and function. The Journal of Immunology. 2026;215(6). doi:10.1093/jimmun/vkag165

BibTeX
@article{Maru2026,
  author = {Maru, Saumya Y and Wetzel, Meredith and Mitchell, Jacob T and Gross, Nicole E and Andaloori, Lalitya and Howe, Kathryn and Kartalia, Emma and Mo, Guanglan and Leatherman, James and Ho, Won Jin and Fertig, Elana J and Kagohara, Luciane T and Pearce, Edward J and Jaffee, Elizabeth M},
  title = {Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and function},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {6},
  doi = {10.1093/jimmun/vkag165}
}
Kostenlos starten →